REFERENCES
[1] Ferlay J, Shin HR, Bray F, et al. Lyon, France: International
Agency for Research on Cancer; 2010. GLOBOCAN 2008 v 1.2, Cancer
Incidence and Mortality Worldwide: IARC Cancer Base No 10
[2] Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC.
Diabetes mellitus and risk of prostate cancer (United
States) Cancer Causes Control. 1998;9:3–9.
[3]. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC.
Height, body weight, and risk of prostate cancer. Cancer Epidemiol
Biomarkers Prev. 1997;6:557–63.
[4]. Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen
MB, et al. Association of smoking, body mass and physical activity with
risk of prostate cancer in the lowa 65+ Rural Health Study (United
States) Cancer Causes Control. 1997;8:229–38.
[5]. Alyson LJ, White E, Kristal AR. Anthropometrics and prostate
cancer risk. Am J Epidemiol. 2007;165:1271–9
[6]. Platz EA, Yeole BB, Cho E, Jussawalla DJ, Giovannucci E,
Ascherio A. Vasectomy and Prostate Cancer: A case - control study in
India. Int J Epidemiol. 1997;26:933–8.
[7]. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on
prostate cancer. Part 1: screening, diagnosis, and treatment of
clinically localised disease. Eur Urol . 2011;59(1):61-71.
doi:10.1016/j.eururo.2010.10.039
[8]. Evans AJ. Treatment effects in prostate cancer. Mod
Pathol . 2018;31(S1):S110-S121. doi:10.1038/modpathol.2017.158
[9] Matsushita M, Fujita K, Nonomura N. Influence of Diet and
Nutrition on Prostate Cancer. Int J Mol Sci . 2020;21(4):1447.
Published 2020 Feb 20. doi:10.3390/ijms21041447
[10] Graff RE, Pettersson A, Lis RT, et al. Dietary lycopene intake
and risk of prostate cancer defined by ERG protein expression. Am
J ClinNutr . 2016;103(3):851-860. doi:10.3945/ajcn.115.118703
[11] A. Kawashima, T. Madarame, H. Koike, Y. Komatsu, J.A. Wise,
Four week supple-mentation with mixed fruit and vegetable juice
concentrates increased protective serum antioxidants and folate and
decreased plasma homocysteine in Japanese subjects, Asia Pac. J. Clin.
Nutr. 16 (2007) 411–421
[12]M. Ono, M. Takeshima, S. Nakano, Mechanism of the Anticancer
Effect of Lycopene(tetraterpenoids), the Enzymes, Elsevier, 2015, pp.
139–166.
[13]V. Bhuvaneswari, S. Nagini, Lycopene: a review of its potential
as an anticanceragent, Curr. Med. Chem. Anticancer Agents 5 (2005)
627–635.
[14]N.F. Gloria, N. Soares, C. Brand, F.L. Oliveira, R. Borojevic,
A.J. Teodoro, Lycopeneand beta-carotene induce cell-cycle arrest and
apoptosis in human breast cancer celllines, Anticancer Res. 34 (2014)
1377–1386.
[15]U.C. Obermüller-Jevic, E. Olano-Martin, A.M. Corbacho, J.P.
Eiserich, A. Van derVliet, G. Valacchi, C.E. Cross, L. Packer, Lycopene
inhibits the growth of normalhuman prostate epithelial cells in vitro,
Nutr. J. 133 (2003) 3356–3360.
[16]Y. Sharoni, M. Danilenko, J. Levy, Molecular mechanisms for the
anticancer activityof the carotenoid lycopene, Drug Dev. Res. 50 (2000)
448–456.
[17]J. Levy, E. Bosin, B. Feldman, Y. Giat, A. Miinster, M.
Danilenko, Y. Sharoni,Lycopene Is a More Potent Inhibitor of Human
Cancer Cell Proliferation Than Eitherα‐carotene orβ‐carotene,(1995).
[18]H. Nagasawa, T. Mitamura, S. Sakamoto, K. Yamamoto, Effects of
lycopene onspontaneous mammary tumour development in SHN virgin mice,
Anticancer Res.15 (1995) 1173–1178.
[19]M.-C. Lin, F.-Y. Wang, Y.-H. Kuo, F.-Y. Tang, Cancer
chemopreventive effects oflycopene: suppression of MMP-7 expression and
cell invasion in human coloncancer cells, J. Agric. Food Chem. 59 (2011)
11304–11318.
[20]D. Li, L. Chen, W. Zhao, J. Hao, R. An, MicroRNA-let-7f-1 is
induced by lycopeneand inhibits cell proliferation and triggers
apoptosis in prostate cancer, Mol. Med.Rep. 13 (2016) 2708–2714.
[21]N.F. Haddad, A.J. Teodoro, F.L. de Oliveira, N. Soares, R.M. de
Mattos, F. Hecht,R.S. Dezonne, L. Vairo, R.C. Dos Santos Goldenberg,
F.C.A. Gomes, Correction: ly-copene and beta-carotene induce growth
inhibition and proapoptotic effects onACTH-Secreting pituitary adenoma
cells, PLoS One 11 (2016) e0149157.
[22]S.-A. Esmaeili, F. Nejatollahi, A. Sahebkar, Inhibition of
intercellular communica-tion between prostate cancer cells by a specific
anti-STEAP-1 single chain antibody,Anticancer Agents Med. Chem. 18
(2018) 1674–1679
[23] Chen P, Zhang W, Wang X, et al. Lycopene and Risk of Prostate
Cancer: A Systematic Review and Meta-Analysis. Medicine
(Baltimore) . 2015;94(33):e1260. doi:10.1097/MD.0000000000001260
[24] Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A
prospective study of tomato products, lycopene, and prostate cancer
risk. J Natl Cancer Inst . 2002;94(5):391-398.
doi:10.1093/jnci/94.5.391
[25] Chen J, Song Y, Zhang L. Lycopene/tomato consumption and the
risk of prostate cancer: a systematic review and meta-analysis of
prospective studies. J NutrSciVitaminol (Tokyo) .
2013;59(3):213-223. doi:10.3177/jnsv.59.213
[26] Chen P, Zhang W, Wang X, et al. Lycopene and Risk of Prostate
Cancer: A Systematic Review and Meta-Analysis. Medicine
(Baltimore) . 2015;94(33):e1260. doi:10.1097/MD.0000000000001260